AMI/ACS Dx: Old EKG - PowerPoint PPT Presentation

1 / 44
About This Presentation
Title:

AMI/ACS Dx: Old EKG

Description:

When comparing to an old EKG, the old EKG should not be one done in the ED at the time of the acute presentation for AMI/ACS The goal is to establish no change as ... – PowerPoint PPT presentation

Number of Views:278
Avg rating:3.0/5.0
Slides: 45
Provided by: EdS147
Category:
Tags: acs | ami | ekg | chest | imaging | old

less

Transcript and Presenter's Notes

Title: AMI/ACS Dx: Old EKG


1
AMI/ACS Dx Old EKG
  • When comparing to an old EKG, the old EKG should
    not be one done in the ED at the time of the
    acute presentation for AMI/ACS
  • The goal is to establish no change as compared to
    baseline, non-ischemia EKG, eg LVH with strain
    pattern

2
EKG Diagnosis LVH with Strain Pattern
  • LVH criteria, ST-T wave changes

3
Diagnosis ECG Monitoring
  • Dysrhythmias
  • Bradycardia
  • Heart blocks
  • Malignant ventricular ectopy
  • Ventricular Fibrillation

4
Bifascicular Block
  • RBBB Opposite T waves normal

5
Non-sustained VT in AMI
6
Non-sustained VT in AMI
7
AMI/ACS DiagnosisCardiac Enzymes
8
AMI/ACS Lab Evaluation
Marker Elevation Peak Duration
Myoglobin 1-4 h 6 h 24 h
Troponin I 3-12 h 18 h 5-10 days
Troponin T 3-12 h 12 h 5-14 days
CK-MB 3-12 h 18-24 h 2 days
9
Cardiac Enzymes CPK-MB
  • CPK-MB
  • Sensitive and specific
  • Limited potential for early diagnosis??
  • Two hour change in CK-MB may be accurate to
    predict ACS

10
Cardiac Enzymes Myoglobin
  • Myoglobin
  • Sensitive but not specific
  • Not used to rule out clinically
  • Peaks earlier than CPK
  • Limited utility given ability to use CK-MB and
    troponin

11
Cardiac Enzymes Troponins
  • Troponins true cardiac markers
  • Touted to be highly specific
  • More sensitive than CPK-MB at detecting small
    infarcts
  • Elevation predicts ? mortality and complications
  • Troponin T less specific than troponin I

12
Cardiac Enzymes Troponins
  • Troponins
  • Can troponin be positive without ACS?
  • What is the significance of isolated troponin
    elevation with neg EKG?
  • Cannot overlook higher complication rate if
    troponin positive

13
AMI/ACS DiagnosisOther Acute Tests
14
AMI/ACS Diagnosis CXR
  • CM, CHF
  • Other causes of chest pain
  • Pneumothorax, rib fractures
  • Pneumonia
  • Aortic dissection
  • Carcinoma

15
AMI/ACS Diagnosis CXR
  • Acute pulmonary edema

16
AMI/ACS Diagnosis Echocardiography
  • What are the indications for echocardiography in
    the ED?
  • How might this data alter the acute management of
    an STEMI patient?

17
AMI/ACS Diagnosis Echocardiography
  • Uncertain ACS diagnosis
  • Uncertain need for acute PCI
  • LV dysfunction suggests more gravely ill AMI
    patient
  • Valvular dysfunction

18
AMI/ACS Diagnosis Echocardiography
  • Sensitive in detecting regional wall motion
    abnormalities
  • Cannot differentiate between ischemia, AMI, or
    old MI
  • Can detect valve stenosis, regurgitation,
    insufficiency

19
AMI/ACS Diagnosis Echocardiography
20
AMI/ACS Diagnosis Stress Testing
  • Measures inducible ischemia
  • Must rule out AMI/ACS first
  • Physical, process limitations
  • Stress thallium may be needed
  • Accuracy, utility can vary
  • Part of a chest pain protocol

21
AMI/ACS Diagnosis Stress Testing
  • Persantine stress test
  • In general, thallium clears more slowly from
    regions supplied by stenotic vessels than from
    normal myocardial regions. Areas of significant
    hypoperfusion will have very slow clearance and
    may even accumulate thallium.

22
AMI/ACS Diagnosis Sestamibi (Cardiolyte) Scanning
  • Technetium
  • Measures focal ischemia
  • Pain for at least 1 hr or ongoing
  • Resolution within 30 min only
  • Poor perfusion, no uptake
  • May lead to early catheterization
  • Part of a chest pain protocol

23
AMI/ACS Diagnosis Sestamibi (Cardiolyte) Scanning
  • Myoview ( technetium Tc-99m tetrofosmin )
  • A cardiac imaging agent, is useful in the
    diagnosis and localization of regions of
    reversible myocardial ischemia in the presence or
    absence of infarction under exercise and rest
    conditions.

24
AMI/ACS DiagnosisChest Pain Protocols
25
AMI/ACS Diagnosis Chest Pain Protocols
  • Low risk population
  • Serial EKGs
  • Serial cardiac enzymes
  • Provocative testing as needed
  • Detects AMI, ACS
  • Identify uncomplicated patients

26
AMI/ACS Diagnosis Chest Pain Protocols
  • The Erlanger chest pain evaluation protocol a
    one-year experience with serial 12-lead ECG
    monitoring, two-hour delta serum marker
    measurements, and selective nuclear stress
    testing to identify and exclude acute coronary
    syndromes.
  • Fesmire F Ann Emer Med 2002
  • CONCLUSION An accelerated chest pain evaluation
    strategy consisting of SECG, 2-hour delta serum
    marker measurements, and selective nuclear stress
    testing in conjunction with physician judgment
    identifies and excludes MI and 30-day ACS during
    the initial evaluation of patients with chest
    pain.

27
(No Transcript)
28
(No Transcript)
29
(No Transcript)
30
AMI/ACS Diagnosis Chest Pain Protocols
  • Delta creatine kinase-MB outperforms myoglobin at
    two hours during the emergency department
    identification and exclusion of troponin positive
    non-ST-segment elevation acute coronary
    syndromes.
  • Fesmire F Ann Emer Med 2004
  • CONCLUSION A 2-hour delta CK-MB level
    outperforms myoglobin level in the early
    identification and exclusion of acute myocardial
    infarction in non-ST-segment elevation chest pain
    patients. This finding suggests that myoglobin
    may no longer be the optimal early marker of
    acute myocardial infarction when troponins are
    used as the criterion standard.

31
(No Transcript)
32
(No Transcript)
33
AMI/ACS DiagnosisGuidelines
34
AMI/ACS Rx Guidelines
  • What guidelines guide AMI Rx?
  • How are these guidelines derived? How are they
    stated

35
ACEP AMI/ACS Guidelines
  • Ann Emer Med, 2000
  • Standards, guidelines, options
  • Criteria emergent reperfusion Rx
  • PTCA within 120 minutes
  • Options for serial enzymes

36
AMI/ACS Diagnosis Clinical Guidelines
  • Low risk population
  • Serial EKGs
  • Serial cardiac enzymes
  • Provocative testing as needed
  • Detects AMI, ACS
  • Identify uncomplicated patients

37
(No Transcript)
38
(No Transcript)
39
(No Transcript)
40
(No Transcript)
41
(No Transcript)
42
(No Transcript)
43
AMI/ACS Diagnosis Conclusions
  • Important clinical disease state
  • Risk stratification key
  • Diagnosis can be made
  • Most tests acutely available
  • A protocol assists in diagnosis

44
AMI/ACS DiagnosisQuestions?
  • www.acc.org or www.americanheart.org
  • www.acep.org
  • www.guidelines.gov
  • PDF file allows for optimal printing
  • edsloan_at_uic.edu (312) 413-7490

ami acs icep part 1 modified 2007
Write a Comment
User Comments (0)
About PowerShow.com